Flavobacterium odoratum: a species resistant to a wide range of antimicrobial agents.
Open Access
- 1 January 1979
- journal article
- research article
- Published by BMJ in Journal of Clinical Pathology
- Vol. 32 (1), 73-77
- https://doi.org/10.1136/jcp.32.1.73
Abstract
During the period 1966-77, 24 strains of Flavobacterium odoratum were identified from among strains of Gram-negative, non-fermentative bacteria submitted to the National Collection of Type Cultures for computer-assisted identification. The F. odoratum strains showed resistance to therapeutic levels of gentamicin, tobramycin, amikacin, and carbenicillin as well as to several other antimicrobial agents generally useful in the treatment of infections caused by Gram-negative, non-fermentative bacteria. Two strains isolated from amputation stumps and another three strains isolated in significant numbers from urine specimens were possibly opportunist pathogens. The biochemical characteristics of the 24 strains, the proposed neotype strain of F. odoratum, and three strains representative of a group, referred to at the Center for Disease Control, Atlanta as group M-4f, were compared with those of biochemically similar species which may be isolated from clinical material.This publication has 5 references indexed in Scilit:
- Revised Description, from Clinical Strains, of Flavobacterium breve (Lustig) Bergey et al. 1923 and Proposal of the Neotype StrainInternational Journal of Systematic and Evolutionary Microbiology, 1978
- Revised Description, from Clinical Isolates, of Flavobacterium odoratum Stutzer and Kwaschnina 1929, and Designation of the Neotype StrainInternational Journal of Systematic and Evolutionary Microbiology, 1977
- Tobramycin, amikacin, sissomicin, and gentamicin resistant Gram-negative rods.BMJ, 1976
- Strains of Pseudomonas putrefaciens from clinical material.Journal of Clinical Pathology, 1975
- Comparison of group IIf withFlavobacterium andMoraxellaAntonie van Leeuwenhoek, 1973